Abstract:Abstract Background Abnormal expression of suppressor of cytokine signaling (SOCS) proteins regulates tumor angiogenesis and development in cancers. In this study, we aimed to perform a comprehensive bioinformatic analysis of SOCS proteins in breast invasive carcinoma (BRCA). Methods The gene expression, methylation level, copy number, protein expression and patient survival data related to SOCS family members in BRCA patients were obtained from the following databases: Oncomine, The Cancer Genome Atlas (TCGA), Genotype-Tissue Expression (GTEx), Human Protein Atlas (HPA), Gene Expression Profiling Interactive Analysis (GEPIA), PCViz, cBioPortal and Kaplan-Meier plotter. Correlation analyses, identification of interacting genes and construction of regulatory networks were performed by functional and pathway enrichment analyses, weighted gene coexpression network analysis (WGCNA) and gene set enrichment analysis (GSEA). Results Data related to 1109 BRCA tissues and 113 normal breast tissue samples were extracted from the TCGA database. SOCS2 and SOCS3 exhibited significantly lower mRNA expression levels in BRCA tissues than in normal tissues. BRCA patients with high mRNA levels of SOCS3 ( p < 0.01) and SOCS4 ( p < 0.05) were predicted to have significantly longer overall survival (OS) times. Multivariate analysis showed that SOCS3 was an independent prognostic factor for OS. High mRNA expression levels of SOCS2 ( p < 0.001), SOCS3 (p < 0.001), and SOCS4 ( p < 0.01), and a low expression level of SOCS5 (p < 0.001) were predicted to be significantly associated with better recurrence-free survival (RFS). Multivariate analysis showed that SOCS2 was an independent prognostic factor for RFS. Lower expression levels of SOCS2 and SOCS3 were observed in patients with tumors of more advanced clinical stage ( p < 0.05). Functional and pathway enrichment analyses, together with WGCNA and GSEA, showed that SOCS3 and its interacting genes were significantly involved in the JAK-STAT signaling pathway, suggesting that JAK-STAT signaling might play a critical role in BRCA angiogenesis and development. Western blot results showed that overexpression of SOCS3 inhibited the activity of the JAK-STAT signaling pathway in vitro. Conclusions SOCS family proteins play a very important role in BRCA. SOCS3 may be a prognostic factor and SOCS2 may be a potential therapeutic target in breast cancer.

Unveiling the pathological functions of SOCS in colorectal cancer: Current concepts and future perspectives

The Role of Suppressor of Cytokine Signaling 3 in Inflammatory Bowel Disease and Its Associated Colorectal Cancer

Suppressor of cytokine signaling 6 in cancer development and therapy: Deciphering its emerging and suppressive roles

The Role and Gene Expression Profile of SOCS3 in Colorectal Carcinoma.

Tumour-promoting role of SOCS1 in colorectal cancer cells

SOCS Proteins in Immunity, Inflammatory Diseases, and Immune-Related Cancer

Identification of SOCS Family Members with Prognostic Values in Human Ovarian Cancer.

Expression Characteristics, Immune Signature, and Prognostic Value of the SOCS Family Identified by Multiomics Integrative Analysis in Liver Cancer

Identification of SOCS2 and SOCS6 as biomarkers in human colorectal cancer

SOCS3 as a potential driver of lung metastasis in colon cancer patients

Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis.

Dysregulated expression of the suppressors of cytokine signaling (SOCS) contributes to the development of prostate cancer

The Neglected Suppressor of Cytokine Signalling (SOCS): SOCS4-7

Suppressors of Cytokine Signaling and Hepatocellular Carcinoma

Unravelling the druggability and immunological roles of the SOCS-family proteins

Comprehensive analysis of suppressor of cytokine signaling proteins in human breast Cancer

Characterization of the Roles of Suppressor of Cytokine Signaling‐3 in Prostate Cancer Development and Progression

SOCS1 expression in cancer cells: potential roles in promoting antitumor immunity

SOCS Signaling in Autoimmune Diseases: Molecular Mechanisms and Therapeutic Implications.

[SOCS3: a Potential Therapeutic Target for Many Human Diseases].

SOCS6 functions as a tumor suppressor by inducing apoptosis and inhibiting angiogenesis in human prostate cancer.